Fiber Appetite Randomized Trial: What the Evidence Says

Quick Answer

Fiber Appetite Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 randomized trial, 1 narrative review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Diets low in fiber and high in processed foods, sugars, fats, and animal proteins - typical of the Western diet - have been found to reduce gut microbial diversity whereas fiber-rich diets like the Mediterranean diet seem to promote microbial diversity and anti-inflammatory stability. [Putz Julia Corinna (2026); evidence level 2]
• Firmicutes/Bacteroidetes 19 21 19 22 19 23 24 27 28 Alterations in gut microbiota composition are associated with obesity, often reflected in changes in theratio. [Putz Julia Corinna (2026); evidence level 2]
• Randomized clinical trials consistently report mean weight loss ranging from approximately 15% to more than 20% of total body weight, accompanied by improvements in glycemic control, cardiometabolic risk factors, and obesity-related comorbidities. [Zambrano-Villacres Raynier (2026); evidence level 3]
• As a result, pharmacotherapy is increasingly positioned as an important component of contemporary obesity treatment algorithms rather than a secondary or last-line option. [Zambrano-Villacres Raynier (2026); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For fiber appetite randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Putz Julia Corinna (2026). Do probiotics modulate dietary intake? Pilot data from a randomized controlled sub-study of the ProBioHRV clinical trial in patients with depression and healthy controls. DOI: 10.1371/journal.pone.0350801. PMCID: PMC13289889. PMID: 42335165. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13289889/
• Zambrano-Villacres Raynier (2026). Nutrition-First Support for GLP-1 and Dual Incretin Therapy in Obesity: A Practical Framework for Dietary Management, Symptom Tolerability, and Long-Term Weight Maintenance. DOI: 10.3390/nu18111751. PMCID: PMC13258902. PMID: 42280393. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13258902/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.